Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039497, "name": "Senores Pharma.", "stock_name": "Senores Pharma.", "full_name": "Senores Pharmaceuticals Ltd", "name_url": "stocks-analysis/senores-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "959.05", "chg": -7.5, "chgp": "-0.78%", "dir": -1, "prev_price": "966.55", "mcapval": "4,416.77 Cr", "mcap": "Small Cap", "scripcode": "544319", "symbol": "SENORES", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0RB801010", "curr_date": "May 11", "curr_time": "", "bse_nse_vol": "2.03 lacs", "exc_status": "Active", "traded_date": "May 11, 2026", "traded_date_str": "2026 05 11", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 980.35", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs98035-3985591", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3985591.png", "date": "2026-05-11 11:11:04", "description": "Surpassing the Rs 980 mark on 11 May 2026, Senores Pharmaceuticals Ltd has reached a fresh 52-week high, marking a remarkable doubling in its share price from the low of Rs 491 over the past year. This milestone is underpinned by a confluence of robust technical indicators and sustained price momentum, even as broader market indices like the Sensex have retreated." }, { "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 979.50 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3985552", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3985552.png", "date": "2026-05-11 10:47:32", "description": "" }, { "title": "Senores Pharmaceuticals Ltd Shows Strong Technical Momentum Amid Bullish Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-shows-strong-technical-momentum-amid-bullish-shift-3984860", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_technicaldot_3984860.png", "date": "2026-05-11 08:03:42", "description": "Senores Pharmaceuticals Ltd has demonstrated a marked shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from mildly bullish to outright bullish. The stock’s recent performance, combined with positive signals from MACD, moving averages, and other momentum oscillators, suggests a strengthening trend that investors should closely monitor." }, { "title": "Senores Pharmaceuticals Gains 8.28%: 4 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-828-4-key-factors-driving-the-weeks-rally-3982612", "imagepath": "", "date": "2026-05-09 09:04:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 5:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>May 8:</strong> New 52-week high of Rs.959</p>\n <p><strong>May 8:</strong> All-time high reached at Rs.957.70</p>\n <p><strong>May 8:</strong> Multibagger returns highlighted amid robust growth and institutional interest</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.892.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.966.55</div><div cl..." }, { "title": "102% Stock Return, 20% Profit Growth: What's Driving Senores Pharmaceuticals Ltd's Multibagger Rerating?", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-delivers-multibagger-returns-amid-robust-growth-and-institutional-interest-3981811", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_multibagger_3981811.png", "date": "2026-05-08 13:35:03", "description": "A 102.36% stock return in one year. An 11.49% growth in net profit over the same period. The gap between those two numbers — roughly 90 percentage points — is driven largely by the market's willingness to pay a higher multiple for each rupee of Senores Pharmaceuticals Ltd's earnings. That divergence is the key to understanding the recent rerating." }, { "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 959", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-of-rs959-3981677", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3981677.png", "date": "2026-05-08 11:10:25", "description": "With a near doubling in price from Rs 474 to Rs 959 over the past year, Senores Pharmaceuticals Ltd has surged to a fresh 52-week high on 8 May 2026, propelled by a confluence of robust technical indicators and sustained price momentum." }, { "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 957.70 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3981622", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3981622.png", "date": "2026-05-08 10:42:25", "description": "Extending its winning streak to four sessions, Senores Pharmaceuticals Ltd surged 2.71% on 8 May 2026 to close at a fresh all-time high of Rs 957.70, just 0.81% above its previous 52-week peak. This rally comes amid broad outperformance against the Sensex, which declined 0.43% on the same day, underscoring the stock’s robust momentum across multiple timeframes." }, { "title": "Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3975095", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_technicaldot_3975095.png", "date": "2026-05-05 08:08:57", "description": "Senores Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, and moving averages reveal a complex interplay of bullish and bearish signals, reflecting cautious optimism among investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Senores Pharmaceuticals Gains 0.93%: 4 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-093-4-key-factors-driving-the-week-3971351", "imagepath": "", "date": "2026-05-02 09:02:46", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> New 52-week and all-time high at Rs.945.95</p>\n <p><strong>28 Apr:</strong> Fresh all-time high of Rs.950 reached</p>\n <p><strong>29 Apr:</strong> Price correction with increased selling pressure</p>\n <p><strong>30 Apr:</strong> Consolidation near weekly close at Rs.898.70</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.890.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.898.70</div><div class=\"stat-change..." } ], "total": 219, "sid": "10039497", "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497" }, "announcements": [ { "caption": "Board Meeting Intimation for Considering And Approving The Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And To Transact Other Business Matters", "datetime": "08-May-2026", "details": "Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Audited Consolidated and Standalone Financial Results Of The Company For The Quarter And financial year Ended March 31 2026 And To Transact Other Business Matters", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "08-May-2026", "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q4FY26 scheduled to be held on May 14 2026 at 05:00 P.M. (IST)", "source": "BSE" }, { "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A", "datetime": "29-Apr-2026", "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Senores Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24290GJ2017PLC100263</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>54.07</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Vinay Kumar Mishra <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@senorespharma.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Deval Rajnikant Shah <br/> Designation: Chief Financial Officer and Whole Time Director <br/> EmailId: dshah@senorespharma.com</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 5: Technical momentum shifts amid mixed indicator signals

May 8: New 52-week high of Rs.959

May 8: All-time high reached at Rs.957.70

May 8: Multibagger returns highlighted amid robust growth and institutional interest

Read full news article

102% Stock Return, 20% Profit Growth: What's Driving Senores Pharmaceuticals Ltd's Multibagger Rerating?

2026-05-08 13:35:03

A 102.36% stock return in one year. An 11.49% growth in net profit over the same period. The gap between those two numbers — roughly 90 percentage points — is driven largely by the market's willingness to pay a higher multiple for each rupee of Senores Pharmaceuticals Ltd's earnings. That divergence is the key to understanding the recent rerating.

Read full news article

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 959

2026-05-08 11:10:25

With a near doubling in price from Rs 474 to Rs 959 over the past year, Senores Pharmaceuticals Ltd has surged to a fresh 52-week high on 8 May 2026, propelled by a confluence of robust technical indicators and sustained price momentum.

Read full news article

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 957.70 as Momentum Builds Across Timeframes

2026-05-08 10:42:25

Extending its winning streak to four sessions, Senores Pharmaceuticals Ltd surged 2.71% on 8 May 2026 to close at a fresh all-time high of Rs 957.70, just 0.81% above its previous 52-week peak. This rally comes amid broad outperformance against the Sensex, which declined 0.43% on the same day, underscoring the stock’s robust momentum across multiple timeframes.

Read full news article

Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:08:57

Senores Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, and moving averages reveal a complex interplay of bullish and bearish signals, reflecting cautious optimism among investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Senores Pharmaceuticals Gains 0.93%: 4 Key Factors Driving the Week

2026-05-02 09:02:46

Key Events This Week

27 Apr: New 52-week and all-time high at Rs.945.95

28 Apr: Fresh all-time high of Rs.950 reached

29 Apr: Price correction with increased selling pressure

30 Apr: Consolidation near weekly close at Rs.898.70

Read full news article

View All News

Sr. No.	Particulars	Details
1	Name of Company	Senores Pharmaceuticals Ltd
2	CIN NO.	L24290GJ2017PLC100263
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	54.07
4	Highest Credit Rating during the previous FY	NA
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	Not Applicable
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE